首页> 外文期刊>Current Protein and Peptide Science >Development of Novel Therapeutic Drugs in Humans from Plant Antimi-crobial Peptides
【24h】

Development of Novel Therapeutic Drugs in Humans from Plant Antimi-crobial Peptides

机译:植物抗微生物肽对人类新型治疗药物的开发

获取原文
获取原文并翻译 | 示例
           

摘要

All living organisms, ranging from microorganisms to plants and mammals, have evolved mechanisms to actively defend themselves against pathogen attack. A wide range of biological activities have been attributed to plant antimicrobial peptides (AMPs) including growth inhibitory effects on a broad range of fungi, Gram-positive and Gram-negative bacteria, viruses, neoplastic cells and parasitic protozoa. Classes of AMPs, their mechanisms of action, biological activity, and cytotoxicity towards host cells are discussed. A particular focus regards AMP candidates with potential for use in defense against biological warfare agents. This field is young, but provides additional stimulus to consideration of these molecules as anew class of therapeutic agents and promises to revolutionize treatment of many infectious diseases.
机译:从微生物到植物和哺乳动物,所有活生物体均已进化出机制来主动防御病原体攻击。植物抗微生物肽(AMP)具有广泛的生物学活性,包括对多种真菌,革兰氏阳性和革兰氏阴性细菌,病毒,肿瘤细胞和寄生虫的生长抑制作用。讨论了AMPs的种类,作用机理,生物学活性和对宿主细胞的细胞毒性。一个特别的重点是有可能用于防御生物战剂的AMP候选人。这个领域还很年轻,但是为将这些分子视为一类新型治疗剂提供了更多的刺激因素,并有望彻底改变许多传染病的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号